Chronic Obstructive Pulmonary Disease as a Predictor of Lung Cancer Mortality
분야
의약학 > 내과학
저자
( Hee Jung Ban ) , ( Yun Hee Kim ) , ( Yu Il Kim ) , ( Hyun Wook Kang ) , ( Jin Yeong Yu ) , ( Bo Ram Lee ) , ( Woo Jin Kim ) , ( Hee Jung Ban ) , ( Yong Soo Kwon ) , ( In Jae Oh ) , ( Kyu Sik Kim ) , ( Young Chul Kim ) , ( Sung Chul Lim )
발행기관
대한결핵 및 호흡기학회
간행물정보
대한결핵및호흡기학회 추계학술발표초록집 2012년, 제114권 204(총1페이지)
파일형식
0y909916.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    1,000원
    적립금
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Background: COPD has reported as a risk factor of lung cancer. However, there is limited data whether COPD can be a predictor of mortality in lung cancer. This study was performed to investigate that COPD can affect the mortality of the patiens with lung cancer. Methods: Patients who were diagnosed with lung cancer during Jan 2007 to Dec 2008 at Chonnam University Hawsun Hospital were analyzed retrospectively. We collected data gender, age, BMI, smoking history, TNM stage, treatment method, spirometry result and identified the state of death. Hazard ratio of mortality in lung cancer patients were calculated for each variables including COPD stage by Cox proportional hazards regression. Results: The variables significantly associated with mortality of patients with lung cancer were gender, age, BMI, smoking history, TNM stage, treatment method, COPD stage by GOLD in univariated analysis. In multivariated analysis, age, BMI, TNM stage, treatment method, and GOLD stage were the significant predictors of mortality in lung cancer. In the univariated analysis, the hazard ratio for normal stage was 1.24 (95% CI 0.92-1.65) in stage 1, 1.65 (95% CI 1.25-2.18) in stage 2, 2.33(95% CI 1.62-3.34) in stage 3. In the multivariated analysis, the hazard ratio for normal stage was 1.10 (95% CI 0.78-1.56) in stage 1, 1.33 (95% CI 0.96-1.85), in stage 2, 1.59 (95% CI 1.04-2.44) in stage 3. Conclusion: This study suggests that COPD is one of the significant factors that predict mortality of lung cancer. COPD should be noted for the reduction of mortality of lung cancer.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.